A Formal Model for the FAIR4Health Information Architecture.

Health Information Systems Organizational Models Systems Analysis

Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
29 Jun 2022
Historique:
entrez: 1 7 2022
pubmed: 2 7 2022
medline: 6 7 2022
Statut: ppublish

Résumé

In the EU project FAIR4Health, a ETL pipeline for the FAIRification of structured health data as well as an agent-based, distributed query platform for the analysis of research hypotheses and the training of machine learning models were developed. The system has been successfully tested in two clinical use cases with patient data from five university hospitals. Currently, the solution is also being considered for use in other hospitals. However, configuring the system and deploying it in the local IT architecture is non-trivial and meets with understandable concerns about security. This paper presents a model for describing the information architecture based on a formal approach, the 3LGM metamodel. The model was evaluated by the developers. As a result, the clear separation of tasks and the software components that implement them as well as the rich description of interactions via interfaces were positively emphasized.

Identifiants

pubmed: 35773907
pii: SHTI220761
doi: 10.3233/SHTI220761
doi:

Types de publication

Journal Article

Langues

eng

Pagination

446-449

Auteurs

Mona Perbix (M)

Institute of Medical Informatics, Statistics and Epidemiology (IMISE), Leipzig University, Germany.

Matthias Löbe (M)

Institute of Medical Informatics, Statistics and Epidemiology (IMISE), Leipzig University, Germany.

Sebastian Stäubert (S)

Institute of Medical Informatics, Statistics and Epidemiology (IMISE), Leipzig University, Germany.

A Anil Sinaci (AA)

SRDC Software Research Development and Consultancy Corporation, Ankara, Turkey.

Mert Gencturk (M)

SRDC Software Research Development and Consultancy Corporation, Ankara, Turkey.

Miriam Quintero (M)

Atos Research and Innovation (ARI), Madrid, Spain.

Alicia Martinez-Garcia (A)

Institute of Biomedicine of Seville (IBIS), Virgen del Rocío University Hospital, University of Seville, Seville, Spain.

Celia Alvarez-Romero (C)

Institute of Biomedicine of Seville (IBIS), Virgen del Rocío University Hospital, University of Seville, Seville, Spain.

Carlos L Parra-Calderon (CL)

Institute of Biomedicine of Seville (IBIS), Virgen del Rocío University Hospital, University of Seville, Seville, Spain.

Alfred Winter (A)

Institute of Medical Informatics, Statistics and Epidemiology (IMISE), Leipzig University, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH